Your browser is no longer supported. Please, upgrade your browser.
SVA Sinovac Biotech Ltd. monthly Stock Chart
SVA [NASD]
Sinovac Biotech Ltd.
Index- P/E- EPS (ttm)-0.19 Insider Own11.40% Shs Outstand56.72M Perf Week1.01%
Market Cap340.89M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float37.70M Perf Month-1.64%
Income-11.00M PEG- EPS next Q- Inst Own39.10% Short Float1.59% Perf Quarter3.98%
Sales52.00M P/S6.56 EPS this Y-150.80% Inst Trans-0.23% Short Ratio7.66 Perf Half Y2.74%
Book/sh1.96 P/B3.07 EPS next Y- ROA-4.70% Target Price6.00 Perf Year18.07%
Cash/sh0.87 P/C6.93 EPS next 5Y12.00% ROE-7.80% 52W Range4.38 - 7.16 Perf YTD1.86%
Dividend- P/FCF- EPS past 5Y47.90% ROI0.80% 52W High-16.06% Beta0.29
Dividend %- Quick Ratio1.70 Sales past 5Y15.10% Gross Margin59.70% 52W Low37.21% ATR0.13
Employees646 Current Ratio2.10 Sales Q/Q-92.40% Oper. Margin-26.10% RSI (14)54.46 Volatility0.84% 3.03%
OptionableYes Debt/Eq0.26 EPS Q/Q-475.30% Profit Margin-18.00% Rel Volume0.75 Prev Close5.99
ShortableYes LT Debt/Eq0.03 EarningsFeb 27 BMO Payout- Avg Volume78.33K Price6.01
Recom3.00 SMA202.05% SMA50-0.36% SMA2000.02% Volume58,667 Change0.33%
Aug-15-14Reiterated Aegis Capital Buy $7 → $10
Aug-15-13Upgrade Aegis Capital Hold → Buy $7
Dec-12-12Initiated Aegis Capital Hold $2.50
Jan-07-11Reiterated Brean Murray Buy $5.50 → $4.80
Jan-04-11Downgrade WBB Securities Buy → Speculative Buy $7.50 → $7.50
Nov-11-10Upgrade Brean Murray Hold → Buy $5.50
Apr-20-10Initiated WBB Securities Buy $7.50
Apr-06-10Downgrade Brean Murray Buy → Hold
Feb-13-09Upgrade SMH Capital Neutral → Accumulate $31 → $27
Jul-09-08Initiated Brean Murray Buy $5
Jan-13-17 11:08AM  Sinovac Biotech Ltd. Value Analysis (NASDAQ:SVA) : January 13, 2017
Jan-12-17 07:19AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : January 12, 2017
Jan-11-17 01:08PM  INVESTOR ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-08-17 09:22PM  SINOVAC NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sinovac Biotech Ltd. To Contact The Firm PR Newswire
Jan-06-17 10:30AM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors Business Wire
Jan-04-17 10:21AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sinovac Biotech Ltd. (SVA) Accesswire
Dec-23-16 03:08PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
01:13PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors Business Wire
06:00AM  Sinovac Responds to Recent Report PR Newswire
Dec-22-16 08:15AM  Is Sinovac Biotech Ltd. (SVA) A Good Stock to Buy? at Insider Monkey +5.23%
Dec-21-16 04:57PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Sinovac Biotech Ltd. and Advises Investors with Losses to Contact the Firm Business Wire
03:16PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sinovac Biotech Ltd. (SVA) PR Newswire
12:45PM  INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sinovac Biotech Ltd. - SVA Business Wire
Dec-16-16 07:37AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : December 16, 2016
Dec-14-16 12:03PM  ETFs with exposure to Sinovac Biotech Ltd. : December 14, 2016
Dec-04-16 03:46PM  Is Boingo Wireless Inc (WIFI) A Good Stock To Buy? at Insider Monkey
Dec-01-16 11:50AM  ETFs with exposure to Sinovac Biotech Ltd. : December 1, 2016
Nov-30-16 09:41AM  Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016
Nov-28-16 07:07AM  Q3 2016 Sinovac Biotech Ltd Earnings Release - Before Market Open
06:12AM  Sinovac posts 3Q profit
06:00AM  Sinovac Reports Unaudited Third Quarter 2016 Financial Results PR Newswire
Nov-15-16 06:00AM  Sinovac to Host Conference Call to Report Third Quarter 2016 Unaudited Financial Results PR Newswire
Nov-07-16 06:00AM  Sinovac Announces Results of 2016 Annual General Meeting of Shareholders PR Newswire
Oct-19-16 08:19AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : October 19, 2016
06:00AM  Sinovac Product Pipeline News PR Newswire
Oct-05-16 08:31AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : October 5, 2016
Sep-30-16 06:00AM  Sinovac Schedules 2016 Annual Meeting of Shareholders PR Newswire
Sep-23-16 09:00AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 23, 2016
Sep-14-16 01:07PM  Sinovac Biotech Ltd. Value Analysis (NASDAQ:SVA) : September 14, 2016
Sep-13-16 08:20AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : September 13, 2016
Aug-31-16 08:56AM  The Market In 5 Minutes: Despite Jump, The 'Fear Index' Still Trading At 52-Week Lows
06:25AM  Heng Ren Rejects Sinovac Insider Buyout Offer
Aug-30-16 08:15AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : August 30, 2016
Aug-23-16 07:07AM  Q2 2016 Sinovac Biotech Ltd Earnings Release - Before Market Open
06:45AM  Sinovac reports 2Q loss
06:00AM  Sinovac Reports Unaudited Second Quarter 2016 Financial Results PR Newswire
Aug-22-16 12:06PM  ETFs with exposure to Sinovac Biotech Ltd. : August 22, 2016
Aug-19-16 08:10AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : August 19, 2016
Aug-15-16 06:00AM  Sinovac to Host Conference Call to Report Second Quarter and 2016 Unaudited Financial Results PR Newswire
Aug-09-16 02:09PM  ETFs with exposure to Sinovac Biotech Ltd. : August 9, 2016
Aug-08-16 08:18AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : August 8, 2016
Jul-21-16 08:13AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : SVA-US : July 21, 2016
Jul-19-16 01:12PM  ETFs with exposure to Sinovac Biotech Ltd. : July 19, 2016
Jun-30-16 12:39PM  ETFs with exposure to Sinovac Biotech Ltd. : June 30, 2016
Jun-28-16 02:08PM  Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
May-26-16 06:09PM  Sinovac posts 1Q profit
06:00PM  Sinovac Reports Unaudited First Quarter 2016 Financial Results PR Newswire
07:07AM  Q1 2016 Sinovac Biotech Ltd Earnings Release - After Market Close
May-20-16 06:00AM  Sinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results PR Newswire
May-03-16 09:05AM  3 Underfollowed Infectious Disease Stocks That Deserve More Attention at 24/7 Wall St.
Apr-29-16 01:04PM  SINOVAC BIOTECH LTD Financials
01:04PM  SINOVAC BIOTECH LTD Financials EDGAR Online Financials
Apr-27-16 08:32AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : April 27, 2016
Apr-26-16 04:12AM  Sinovac Files 2015 Annual Report on Form 20-F PR Newswire
Apr-14-16 06:00AM  Sinovac Special Committee Engages Financial and Legal Advisors PR Newswire
Apr-11-16 08:57AM  Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q4, 2015 By the Numbers
07:53AM  Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: 2015 By the Numbers
Apr-05-16 07:07AM  Q4 2015 Sinovac Biotech Ltd Earnings Release - Before Market Open
06:37AM  Sinovac posts 4Q profit
06:16AM  Sinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results PR Newswire
Mar-29-16 06:33AM  Sinovac to Host Conference Call to Report Fourth Quarter... at noodls
06:00AM  Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2015 Unaudited Financial Results PR Newswire
Mar-28-16 06:27PM  Sinovac Adopts Shareholder Rights Plan and Declares Divi... at noodls
06:00PM  Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights PR Newswire
Feb-06-16 10:15AM  Top 4 BioPharma Movers of the Week at 24/7 Wall St.
Feb-04-16 09:55AM  Will Sinovac Go Through With This Buyout? at 24/7 Wall St. +15.40%
09:32AM  Sinovac Biotech Ltd. Stock Surged Amid 'Hostile Takeover'
06:09AM  Sinovac Announces Receipt of Competing Non-Binding "Going Private" Proposal PR Newswire
Feb-02-16 05:19PM  Sinovac Biotech Ltd. Value Analysis (NASDAQ:SVA) : February 2, 2016
08:07AM  Sinovac Biotech Ltd. breached its 50 day moving average in a Bullish Manner : February 2, 2016
Feb-01-16 11:49AM  Why Sinovac's Super Bowl Moment Is Lost On U.S. Shareholders +15.54%
11:23AM  Sinovac Biotech Confirms Acquisition Offer, Shares Spike
06:10AM  Sinovac Announces Receipt of a Preliminary Non-Binding P... at noodls
06:00AM  Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee PR Newswire
Jan-28-16 06:21AM  Sinovac Biotech Announces Issuance of GMP Certificate fo... at noodls
06:00AM  Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine PR Newswire
Jan-04-16 06:00AM  Sinovac Obtains New Drug Certificate and Production License for EV71 Vaccine PR Newswire
Dec-22-15 11:31AM  Sinovac Biotech Ltd. Earnings Analysis: Q3, 2015 By the Numbers
Dec-10-15 11:26AM  Here is What Hedge Funds Think About Sinovac Biotech Ltd. (SVA) at Insider Monkey
05:31AM  Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate PR Newswire
Dec-07-15 08:40AM  Strength Seen in Sinovac Biotech (SVA): Stock Jumps 8.4%
Nov-30-15 01:06AM  Smart Money Pouring Into Applied Optoelectronics Inc (AAOI) at Insider Monkey
Nov-12-15 11:49AM  Edited Transcript of SVA earnings conference call or presentation 12-Nov-15 1:00pm GMT
Nov-11-15 06:05PM  Sinovac reports 3Q loss
06:00PM  Sinovac Reports Unaudited Third Quarter Financial Results PR Newswire
07:07AM  Q3 2015 Sinovac Biotech Ltd Earnings Release - After Market Close
Nov-04-15 06:00AM  Sinovac to Participate in Morgan Stanley Asia Pacific Summit PR Newswire
Nov-02-15 06:00AM  Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results PR Newswire
Oct-26-15 06:00AM  Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate PR Newswire
Oct-01-15 11:12AM  Sinovac Biotech Ltd. Earnings Q2, 2015
Sep-14-15 06:00AM  Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing PR Newswire
Sep-10-15 06:00AM  Sinovac to Participate in Morgan Stanley Global Healthcare Conference PR Newswire
Aug-13-15 09:06AM  Edited Transcript of SVA earnings conference call or presentation 13-Aug-15 12:00pm GMT
Aug-12-15 05:07PM  Sinovac posts 2Q profit +5.26%
04:30PM  Sinovac Reports Unaudited Second Quarter Financial Results PR Newswire
07:07AM  Q2 2015 Sinovac Biotech Ltd Earnings Release - After Market Close
Aug-11-15 06:00AM  Sinovac Announces Results of 2015 Annual General Meeting of Shareholders PR Newswire
Aug-04-15 06:00AM  Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results PR Newswire
Jul-08-15 06:00AM  Sinovac Schedules 2015 Annual Meeting of Shareholders PR Newswire
May-15-15 07:07AM  Q1 2015 Sinovac Biotech Ltd Earnings Release - Before Market Open
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against hepatitis A, hepatitis B, seasonal influenza, H5N1 and H1N1 pandemic influenza, and mumps in the People's Republic of China. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; and Split viron pandemic influenza vaccine. The company also develops the EV71 vaccine, which has completed Phase III clinical trial. In addition, it has completed pre-clinical studies for varicella, sabin inactivated polio, and hepatitis A and B vaccines; and focuses on commencing clinical trials for pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine, and rubella vaccine. The company has a collaboration agreement with GlaxoSmithKline Biologicals SA to develop combination vaccines containing measles for the China market; Tianjin CanSino Biotechnology Inc. to develop a pneumococcal conjugate vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to H5N1 influenza virus strain production for vaccines. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.